Mark Sheptoff Financial Planning’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-320
Closed -$510K 382
2018
Q1
$510K Sell
320
-87
-21% -$139K 0.35% 63
2017
Q4
$364K Hold
407
0.24% 82
2017
Q3
$146K Buy
407
+180
+79% +$64.6K 0.1% 125
2017
Q2
$66K Buy
227
+174
+328% +$50.6K 0.05% 159
2017
Q1
$19K Sell
53
-154
-74% -$55.2K 0.01% 231
2016
Q4
$38K Buy
207
+67
+48% +$12.3K 0.03% 190
2016
Q3
$36K Buy
+140
New +$36K 0.03% 188